BMY · Healthcare

BRISTOL MYERS SQUIBB CO

Ranked earnings events from SEC filings, earnings calls, press releases and news. Full Picture: what to focus on this earnings window

News · 2026-08-07

Licensing / Collaboration DealsImportance 31 · Surprise 42
Bristol Myers Squibb agreed with Schrödinger to deploy the Bunsen agentic AI co-scientist across BMS research operations. The collaboration expands BMS's use of Schrödinger's computational platform for molecular…

Regulatory Approval MilestonesImportance 41 · Surprise 60
The U.S. Food and Drug Administration approved Replimune's Tudriqev in combination with Bristol Myers Squibb's Opdivo for a difficult-to-treat form of advanced melanoma. The decision was supported by a 24.2% tumor…
AI Drug Discovery CollaborationImportance 31 · Surprise 42
Bristol Myers Squibb agreed with Schrödinger to deploy the Bunsen agentic AI co-scientist across BMS research operations. The collaboration expands BMS's use of Schrödinger's computational platform to support molecular…

Acquisition / Partnership / DivestitureImportance 71 · Surprise 60
Bristol Myers Squibb was reported to have held early-stage merger discussions with AstraZeneca for a potential combination valued at approximately $400 billion. The proposed transaction would combine major oncology,…
AI Drug Discovery CollaborationImportance 31 · Surprise 42
Bristol Myers Squibb agreed with Schrödinger to deploy the Bunsen agentic AI co-scientist across BMS research operations. The collaboration expands BMS's use of Schrödinger's computational platform to support molecular…

Acquisition / Partnership / DivestitureImportance 71 · Surprise 60
Bristol Myers Squibb was reported to have held early-stage merger discussions with AstraZeneca for a potential combination valued at approximately $400 billion. The proposed transaction would combine major oncology,…